Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012

Sawyer, Mark; Liang, Jennifer L.; Messonnier, Nancy; Clark, Thomas A.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Superseded

This Document Has Been Replaced By: Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012

February 22, 2013
By Sawyer, Mark ; Liang, Jennifer L. ; Messonnier, Nancy ; ...
Source: MMWR. Morbidity and mortality weekly report. 2013; 62(07):131-5
Series: MMWR. Morbidity and mortality weekly report

[PDF-91.36 KB]

English

Details Related Documents You May Also Like

Details:

Journal Article:

MMWR. Morbidity and mortality weekly report.
Personal Author:

Sawyer, Mark ; Liang, Jennifer L. ; Messonnier, Nancy ; Clark, Thomas A.

Sawyer, Mark ; Liang, Jennifer L. ; Messonnier, Nancy ; Clark, Thomas A. Less -
Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. ; United States. Advisory Committee on Immunization Practices.

National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. ; United States. Advisory Committee on Immunization Practices. Less -
Description:

In October 2011, in an effort to reduce the burden of pertussis in infants, the Advisory Committee on Immunization Practices (ACIP) recommended that unvaccinated pregnant women receive a dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap). Vaccination of women with Tdap during pregnancy is expected to provide some protection to infants from pertussis until they are old enough to be vaccinated themselves. Tdap given to pregnant women will stimulate the development of maternal antipertussis antibodies, which will pass through the placenta, likely providing the newborn with protection against pertussis in early life, and will protect the mother from pertussis around the time of delivery, making her less likely to become infected and transmit pertussis to her infant. The 2011 Tdap recommendation did not call for vaccinating pregnant women previously vaccinated with Tdap. On October 24, 2012, ACIP voted to recommend use of Tdap during every pregnancy. This report summarizes data considered and conclusions made by ACIP and provides guidance for implementing its recommendations. These updated recommendations on use of Tdap in pregnant women aim to optimize strategies for preventing pertussis morbidity and mortality in infants.
Subjects:

[+]

Diphtheria-Tetanus-acellular Pertussis Vaccines/administration & Dosage Diphtheria-Tetanus-acellular Pertussis Vaccines/adverse Effects Female Humans Immunity, Maternally-Acquired Immunization Schedule Infant, Newborn Interpersonal Relations Pregnancy Pregnancy Complications/immunology Pregnancy Trimester, Third Vaccination/standards Whooping Cough/immunology Whooping Cough/prevention & Control
Source:

MMWR. Morbidity and mortality weekly report. 2013; 62(07):131-5
Series:

MMWR. Morbidity and mortality weekly report
Document Type:

Journal Article
Genre:

Practice Guideline
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:899124767ffc7352d4e961584f743374bd25d5f5b5739e9145e59f55688cc10f
Download URL:

https://stacks.cdc.gov/view/cdc/21570/cdc_21570_DS1.pdf
File Type:

No Additional Files

More +

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010

[PDF - 229.21 KB]

:

United States. Advisory Committee on Immunization Practices.

January 14, 2011 | MMWR. Morbidity and mortality weekly report. 2011; 60(1):13-5.

Description:

Despite sustained high coverage for childhood pertussis vaccination, pertussis remains poorly controlled in the United States. A total of 16,858 pertu...

Status:

superseded

File Type:

[PDF - 229.21 KB]

File Type:

[PDF - 229.21 KB]
Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children

[PDF - 1.60 MB]

:

United States. Advisory Committee on Immunization Practices. ...

October 3, 2008 | MMWR. Morbidity and mortality weekly report. 2008; 57(39):1079-80.

Description:

On June 20, 2008 the Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), in...

Status:

superseded

File Type:

[PDF - 1.60 MB]

File Type:

[PDF - 1.60 MB]
Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose

[PDF - 1.60 MB]

October 3, 2008 | MMWR. Morbidity and mortality weekly report. 2008; 57(39):1078-9.

Description:

On June 24, 2008, the Food and Drug Administration licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) and inac...

Status:

superseded

File Type:

[PDF - 1.60 MB]

File Type:

[PDF - 1.60 MB]
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months -- Advisory Committee on Immunization Practices (ACIP), 2011

[PDF - 230.54 KB]

:

United States. Advisory Committee on Immunization Practices.

October 21, 2011 | MMWR. Morbidity and mortality weekly report. 2011; 60(41):1424-6.

Description:

Compared with older children and adults, infants aged <12 months have substantially higher rates of pertussis and the largest burden of pertussis-rela...

Status:

superseded

File Type:

[PDF - 230.54 KB]

File Type:

[PDF - 230.54 KB]
FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine;

[HTM]

:

Centers for Disease Control and Prevention (U.S.)

April 17, 2009 | MMWR. Morbidity and mortality weekly report. 2009; 58(14):374-5.

Description:

On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced diphtheria toxoid and ...

Status:

superseded

File Type:

[HTM]

File Type:

[HTM]
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants : recommendations of the Advisory Committee on Immunization Practices

[PDF - 492.21 KB]

Personal Author:

Broder, Karen R. ;

Brown, Kristin H.
...

May 30, 2008 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 57, no. RR-4

Description:

"In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines were licensed and recommended for use in adults and a...

Status:

superseded

File Type:

[PDF - 492.21 KB]

File Type:

[PDF - 492.21 KB]

Superseded

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012

Details:

Supporting Files

Related Documents

You May Also Like